메뉴 건너뛰기




Volumn 2, Issue 4, 2001, Pages 195-204

Design and intermediate results of the Lower Extremity Arterial Disease Event Reduction (LEADER) trial of bezafibrate in men with lower extremity arterial disease

Author keywords

Arterial disease; Bezafibrate; Fibrinogen; Lipid profile

Indexed keywords

BEZAFIBRATE; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

EID: 0034889909     PISSN: 14686708     EISSN: None     Source Type: Journal    
DOI: 10.1186/CVM-2-4-195     Document Type: Article
Times cited : (31)

References (26)
  • 1
    • 0032513756 scopus 로고    scopus 로고
    • Association of fibrinogen. C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analysis of prospective studies
    • (1998) JAMA , vol.279 , pp. 1477-1482
    • Danesh, J.1    Collins, R.2    Appleby, P.3    Peto, R.4
  • 6
    • 0002821268 scopus 로고
    • The epidemiology of atheroma, thrombosis and ischaemic heart disease
    • 3rd edn. Edited by Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD. Edinburgh: Churchill Livingstone
    • (1994) Haemostasis and Thrombosis , pp. 1199-1227
    • Meade, T.W.1
  • 10
  • 12
    • 0027987849 scopus 로고
    • Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
    • The Scandinavian Simvastatin Survival Study Group
    • (1994) Lancet , vol.344 , pp. 1383-1389
  • 13
    • 0032562005 scopus 로고    scopus 로고
    • Thrombosis prevention trial: Randomised trial of low-intensity oral coagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. A report form the Practice Research Framework
    • General Practice Research Framework
    • (1998) Lancet , vol.351 , pp. 233-241
  • 16
    • 20244370323 scopus 로고
    • Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease
    • The BIP Study Group (the Bezafibrate Infarction Prevention Trial).
    • (1993) Am J Cardiol , vol.71 , pp. 909-915
  • 17
    • 0034604225 scopus 로고    scopus 로고
    • Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease
    • The BIP Study Group
    • (2000) Circulation , vol.102 , pp. 21-27
  • 19
    • 0035941990 scopus 로고    scopus 로고
    • Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: The Diabetes Atherosclerosis Intervention Study, a randomised study
    • Diabetes Atherosclerosis Intervention Study Investigators
    • (2001) Lancet , vol.357 , pp. 905-910
  • 23
    • 0018117095 scopus 로고
    • Cooperative trial in the primary prevention of ischaemic heart disease using clofibrate
    • Committee of Principal Investigators
    • (1978) Br Heart J , vol.40 , pp. 1069-1118


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.